Showing results (81-90 of 156) with videos related to

Sort By:
Pageof 16
European Journal of Preventive Cardiology|June 13, 2025
Rationale for the Routine Screening of Lipoprotein (a) in Cardiovascular Risk AssessmentIulia Iatan, Marlys L Koschinsky, Logan Trenaman, et al.
JAMA Cardiology|September 14, 2022
Burden of Rare Genetic Variants in Spontaneous Coronary Artery Dissection With High-risk FeaturesYu Wang, Andrew Starovoytov, Andrea M Murad, et al.
British Journal of Clinical Pharmacology|September 20, 2016
Prevalence and characteristics of adverse drug reactions at admission to hospital: a prospective observational studySze Ling Chan, Xiaohui Ang, Levana L Sani, et al.
European Journal of Preventive Cardiology|September 1, 2022
Effect of the LDL receptor mutation type on incident major adverse cardiovascular events in familial hypercholesterolaemiaMartine Paquette, Alain Carrié, Sophie Bernard, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 30, 2023
Increased FH-Risk-Score and Diabetes Are Cardiovascular Risk Equivalents in Heterozygous Familial HypercholesterolemiaMartine Paquette, Bertrand Cariou, Sophie Bernard, et al.
American Heart Journal Plus : Cardiology Research and Practice|April 1, 2024
The design and rationale of the Advancing Cardiac Care Unit-based Rapid Assessment and Treatment of hypErcholesterolemia (ACCURATE) studyJunran J Peng, Navid Saleh, Thomas M Roston, et al.
Pharmacogenomics|June 9, 2017
Pharmacogenomics in Asia: a systematic review on current trends and novel discoveriesHazel Xiaohui Ang, Sze Ling Chan, Levana L Sani, et al.
Journal of Clinical Lipidology|November 5, 2023
Sex differences in the perception of cardiovascular risk in familial hypercholesterolemiaBalaqis Alshibani, Iulia Iatan, Amanda Guerin, et al.
Clinical Pharmacology and Therapeutics|October 6, 2016
Development and validation of algorithms for the detection of statin myopathy signals from electronic medical recordsS L Chan, M Y Tham, S H Tan, et al.
Pageof 16